Smart Pills Global Market Report 2024

The smart pills market size has grown rapidly in recent years. It will grow from $4.98 billion in 2023 to $5.53 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%.

The expansion observed in the historical period can be attributed to factors such as the focus on medication adherence, the management of chronic diseases, the involvement of smart pills in clinical trials and research, and the impact of an aging population.

The smart pills market size is expected to see rapid growth in the next few years. It will grow to $8.49 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The anticipated growth in the forecast period can be linked to remote patient monitoring, the influence of regulatory and quality standards, continued utilization of smart pills in clinical trials and research, and the integration of digital health technologies. Notable trends expected during the forecast period encompass wireless health monitoring, the development of diagnostic and imaging capsules, the utilization of data analytics and artificial intelligence, advancements in smart pill sensors, and the emphasis on miniaturization and biocompatibility.

The primary applications of smart pills encompass capsule endoscopy, patient monitoring, and drug delivery. Patient monitoring involves the repeated or continuous tracking of various patient parameters. Smart pills are used to target specific areas within the gastrointestinal tract, including the esophagus, stomach, small intestine, and large intestine, for the treatment of conditions such as esophageal diseases, colon diseases, small bowel diseases, among others. These smart pills find utility in a variety of healthcare settings, including hospitals, diagnostic centers, and research institutes.

The smart pills market research report is one of a series of new reports that provides smart pills market statistics, including smart pills industry global market size, regional shares, competitors with a smart pills market share, detailed smart pills market segments, market trends and opportunities, and any further data you may need to thrive in the smart pills industry. This smart pills market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The smart pills market is experiencing growth, driven by the increasing preference for non-invasive procedures. Non-invasive procedures refer to diagnostic and treatment methods that do not require incisions or tissue removal. Smart pills, which are wireless, ingestible capsules, are easily swallowed and have a wide range of applications in capsule endoscopy, drug delivery, and patient monitoring. For example, they play a crucial role in diagnostic imaging, particularly in capsule endoscopy, a procedure where a smart pill with a micro-camera is swallowed to capture images of the esophagus, stomach, and small intestine as it traverses the gastrointestinal (GI) tract. Smart pills have transformed the diagnosis of gastrointestinal disorders and have the potential to replace conventional techniques like endoscopy. Consequently, the preference for non-invasive procedures is a key driver of the smart pills market.

The growth of the smart pills market is expected to be further fueled by the increasing prevalence of gastrointestinal disorders. Gastrointestinal disorders affect the digestive system, including the stomach, intestines, and associated organs. Smart pills equipped with sensors and technology are utilized for monitoring and diagnosing gastrointestinal disorders, providing valuable insights into digestive system function. For example, as of September 2022, the National Library of Medicine reports that over 40% of people worldwide experience gastrointestinal problems such as diarrhea, constipation, and irritable bowel syndrome (IBS), with prevalence rates of 4.7%, 11.7%, and 4.1%, respectively. Therefore, the rising incidence of gastrointestinal disorders is a significant driver of the smart pills market.

The high cost of smart pills associated with technological advancements poses a restraint to market growth. The integration of advanced technologies, including software upgrades and innovative systems, and the incorporation of microchips contribute to the elevated manufacturing costs of smart pills. Smart pills represent a fusion of drug and device technology, offering a novel approach to drug delivery by embedding sensors and cameras into small ingestible devices. While these devices enable improved diagnostics, monitoring, and treatment of critical medical conditions by allowing real-time patient monitoring, their high cost limits their utilization in underdeveloped regions. Hence, the elevated cost is considered a hindrance to the growth of the smart pills market.

Extensive research and development efforts are underway to harness miniature chips like Addressable Transmitters Operated as Magnetic Spins (ATOMS) for use in smart pills. ATOMS are silicon chip devices that use magnetic resonance imaging (MRI) principles to pinpoint the location of atoms within a patient's body using magnetic fields. They can be employed in ingestible smart pills for disease diagnosis and treatment from within the body, monitoring the gastrointestinal tract, blood, brain, and various health indicators like pH, temperature, pressure, and sugar concentrations. Additionally, they can be programmed to release medications. For instance, scientists at Caltech (California Institute of Technology) have developed a miniature medical chip for potential use as a smart pill.

Major companies in the smart pills market are concentrating on developing smart pills with customizable programs to gain a competitive advantage. Smart pills with customizable programs enable personalized drug delivery and health monitoring, enhancing patient care and treatment effectiveness. For example, in September 2022, HealthBeacon PLC, an Irish digital therapeutics company, introduced the HB Smart Pills Solution, aiding patients in managing up to nine oral medications at home. This technology aims to improve medication adherence, addressing the issue where one in two patients struggles to adhere to their medication schedules. The HB Smart Pills Solution seamlessly integrates with patient support programs, offering customizable options for patients as standalone solutions or as part of existing offerings.

Major companies operating in the smart pills market include Medtronic PLC, Olympus Corporation, CapsoVision Inc., Novartis AG, Proteus Digital Health Inc., Koninklijke Philips N.V., MicroCHIPS Inc., Bio-Images Drug Delivery (BDD) Ltd., Given Imaging Ltd., Vitality Inc., Boston Scientific Corporation, HQ Inc., Fujifilm Holdings Corporation, General Electric Company, Check-Cap Ltd., IntroMedic Co. Ltd., Jinshan Science & Technology Co. Ltd., PENTAX Medical, etectRx Inc., Pixie Scientific HQ Inc., ANX Robotica Corp., RF Co. Ltd., Shenzhen Jifu Medical Technology Co. Ltd., Otsuka America Pharmaceutical Inc., Medimetrics Personalized Drug Delivery B.V., Smart Pill Inc., Medisafe Inc., AdhereTech LLC, TabSafe Medical Services Inc.

North America was the largest region in the smart pills market in 2023. Western Europe was the second-largest region in the smart pills market analysis. The regions covered in the smart pills market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the smart pills market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The smart pills market consists of sales of instruments that are used in applications such as capsule endoscopy, drug delivery, and patient monitoring. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.